• Smart Money
  • Posts
  • This $6bn Activist Billionaire Went All-In on Steel and Utilities

This $6bn Activist Billionaire Went All-In on Steel and Utilities

Health Care, Coupang, and a whole lot of alpha. We dug into his portfolio and backtested 7 years of his top picks.

TL;DR: TODAY’S EDITION
  • Daniel Loeb’s Third Point is one of the most aggressive, high-conviction hedge funds out there

  • He’s currently betting big on steel, biotech, utilities, and a handful of high-beta growth names

  • But 2025 hasn’t been kind: his portfolio is down –3.4% YTD, while the S&P is up +6.1%

  • We ran a 15-year backtest of copying Loeb’s top 10 holdings — and the results are a mixed bag

DAN LOEB

Who is Daniel Loeb?

Daniel Loeb isn’t just a hedge fund manager — he’s an activist juggernaut.

He built Third Point into a ~$6B vehicle that doesn’t just buy stock — it changes companies. Loeb has pushed out CEOs, broken up conglomerates, and agitated for buybacks and spin-offs.

He doesn’t buy and hope — he buys and shakes things up.

But in recent years, performance hasn’t always matched his headlines.

🔍 So, What’s He Holding Right Now?

Here’s what’s inside Third Point’s Q1 2025 portfolio — and why it matters:

⚡ PG&E Corp (PCG) – 12.7% of the portfolio

Loeb’s biggest bet right now is on California-based utility PG&E — a name that’s gone from disaster headline to deep-value turnaround.

🏗️ U.S. Steel (X) – 7.7%

He added +238% to this stake — a bold move. It’s now his second-biggest position. Likely a macro call on industrial demand or an M&A angle. A very “Loeb” style distressed value play.

🛒 Amazon (AMZN) – 6.4%

Still a core holding, though he trimmed ~32% last quarter. Possibly rebalancing after growth’s rebound in 2024. Amazon gives him stable mega-cap exposure.

🇹🇼 Taiwan Semiconductor (TSMC) – 4.3%

A passive hold this quarter, but a strong play on AI, chip supply, and geopolitical optionality. He’s been in it since Q2 2023 — not early, but not late either.

🎟️ Live Nation (LYV) – 4.0%

Loeb added +22% this quarter. The ultimate revenge travel + entertainment stock. He might be betting on continued pricing power and elevated margins.

🔌 Telephone & Data Systems (TDS) – 3.8%

A utility stock with a tech-y twist. He added 13% last quarter. Not flashy, but possibly a dividend + restructuring play.

🏗️ CRH plc (CRH) – 3.4%

Europe-based building materials firm. Infrastructure + inflation hedge. Flat this quarter — but could be part of a broader rotation into real assets.

🏢 Brookfield (BN) – 3.2%

Cut by ~15%, but still notable. Brookfield is one of the biggest players in global infrastructure and real estate. This could be a longer-term “alternative assets” exposure.

🧴 Kenvue (KVUE) – 3.1%

A new position. This is the J&J consumer health spin-off — think Band-Aid, Tylenol, Listerine. Loeb might be betting on cost cuts and brand monetization.

🎰 Flutter Entertainment (FLUT) – 3.1%

An online sports betting giant, especially in the UK and US. A niche but fast-growing segment. Loeb added 11.5% in Q1.

📈 What If You’d Copied Him?

We backtested a strategy where you simply replicate Loeb’s top 10 positions every quarter.

Here’s what that would’ve returned compared to the S&P 500:

Year

Loeb

S&P 500 TR

Delta

2009

29,92%

26,46%

3,45%

2010

31,66%

15,06%

16,60%

2011

5,11%

2,11%

3,00%

2012

23,05%

16,00%

7,04%

2013

59,47%

32,39%

27,08%

2014

1,40%

13,69%

-12,29%

2015

0,88%

1,38%

-0,50%

2016

3,34%

11,96%

-8,62%

2017

36,25%

21,83%

14,42%

2018

-8,18%

-4,38%

-3,80%

2019

33,31%

31,49%

1,83%

2020

16,12%

18,40%

-2,28%

2021

19,46%

28,71%

-9,25%

2022

-25,23%

-18,11%

-7,12%

2023

13,00%

26,29%

-13,28%

2024

19,97%

25,02%

-5,05%

2025

-3,40%

6,09%

-9,49%

Net result: Loeb’s strategy can absolutely crush it… but only sometimes.

Over the past 5 years, he’s underperformed the S&P in 4 of them.

🧩 Why Are His Returns So Volatile?

Because he’s not trying to track the market — he’s trying to beat it with bold moves:

  • 🏭 Going heavy into steel ($X), materials, and utilities

  • 🔬 Holding concentrated biotech bets like Natera and Teva

  • 🛠️ Taking activist-style positions where he can influence the outcome

  • 🔄 Rebalancing quarterly with sometimes huge moves (like +238% in $X)

It’s high-conviction, high-volatility investing — and it’s not for the faint of heart.

🧠 So… Should You Follow Him?

If you’re looking for the next 10x stock and are willing to stomach a few –30% drawdowns?

Sure, keep an eye on Loeb.

But if you’re chasing consistent outperformance? Copying him blindly probably won’t work.

The recent data shows: his hits are big, but his misses are loud.

Want to Copy Investors That Actually Outperform?

With Smart Money Premium, you don’t need to guess who’s hot. We track the top 20 investors based on 3-, 5-, and 7-year performance, then show you:

  • Their current top holdings

  • Their performance vs. the S&P

  • Who’s worth copying right now

Example? One manager has just 2 stocks — and you’d be up +118% YTD if you followed them.

👉 Upgrade now and start replicating smart money today

🫶 BE THE FRIEND WITH THE GOOD TIPS

Know someone always wondering, “Which stock should I buy next?” Share this article with them! It’s a simple way to start investing like the pros — no need to figure it all out yourself when Smart Money’s already done the work. They’ll thank you later.

💬 I’D LOVE TO HEAR FROM YOU

To respond to this newsletter, just hit reply. I love getting replies, and read them all.

If you received this email from a friend, and would like to subscribe, please go here.

🚀 READY TO INVEST SMARTER?

Whenever you’re ready to take it up a notch, Smart Money Premium gives you access to the top 20 investors’ portfolios, backtested over 3, 5, and 7 years for you to copy.

DISCLAIMER

Smart Money is a publisher of financial information, not an investment advisor. The content provided by Smart Money is for informational purposes only and is not personalized or tailored to the needs of any particular recipient. While efforts are made to ensure accuracy, Smart Money does not guarantee the completeness or reliability of the information on this page. All statements and expressions reflect the opinion of the author or a paid advertiser.

The information contained on this website is not, and should not be construed as, investment advice. It does not purport to express any opinion as to the price at which the securities of any company may trade at any time. The information and opinions provided should not be taken as specific advice on the merits of any investment decision. Investors should conduct their own research and make decisions based on their individual review of publicly available information. Smart Money does not provide individualized investment advice, and investors should seek professional guidance based on their own circumstances before making investment decisions.

No statement or opinion herein constitutes an offer or solicitation to buy or sell any securities or financial instruments mentioned.

Smart Money accepts no liability whatsoever for any direct or consequential loss arising from any use of the information provided.